Cited by 106Drug Transport and Resistance MechanismsMicrotubule and mitosis dynamicsAntibiotic Resistance in Bacteria

Origin of multidrug resistance in cells with and without multidrug resistance genes: Chromosome reassortments catalyzed by aneuploidy

Open access
Duesberg, Peter, Stindl, Reinhard, Hehlmann, Ruediger·2001·Proceedings of the National Academy of Sciences

Abstract

Cancer cells and aneuploid cell lines can acquire resistance against multiple unrelated chemotherapeutic drugs that are over 3,000-fold those of normal levels and display spontaneous resistances up to 20-fold of normal levels. Two different mechanisms were proposed for this phenotype: (i) classical mutation of drug metabolizing genes or (ii) chromosome reassortments, catalyzed by cancer- and cell line-specific aneuploidy, which generate, via new gene dosage combinations, a plethora of cancer phenotypes, including drug resistance. To distinguish between these mechanisms, we have asked whether three mouse cell lines can become drug resistant, from which two or three genes have been deleted, and on which multidrug resistance is thought to depend: Mdr1a, Mdr1b, and Mrp1. Because all three lines could acquire multidrug resistance and were aneuploid, whereas diploid mouse cells could not, we conclude that aneuploid cells become drug resistant via specific chromosome assortments, independent of putative resistance genes. We have asked further whether aneuploid drug-resistant Chinese hamster cells revert spontaneously to drug sensitivity in the absence of cytotoxic drugs at the high rates that are typical of chromosome reassortments catalyzed by aneuploidy or at the very low or zero rates (i.e., deletion) of gene mutation. We found that four drug-resistant hamster cell lines reverted to drug sensitivity at rates of about 2-3% per generation, whereas two closely related lines remained resistant under our conditions. Thus, the karyotypic instability generated by aneuploidy emerges as the common source of the various levels of drug resistance of cancer cells: minor spontaneous resistances reflect accidental chromosome assortments, the high selected resistances reflect complex specific assortments, and multidrug resistance reflects new combinations of unselected genes located on the same chromosomes as selected genes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.201398998

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 21

  1. [2]Skipper H E. Cancer Res. 1965;25:1544–1550. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/5861078/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&author=H%20E%20Skipper&volume=25&publication_year=1965&pages=1544-1550&pmid=5861078&)]
  2. [11]Biedler J L, Riehm H. Cancer Res. 1970;30:1174–1184. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/5533992/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&author=J%20L%20Biedler&author=H%20Riehm&volume=30&publication_year=1970&pages=1174-1184&pmid=5533992&)]
  3. [13]Cui Y, Konig J, Buchholz J K, Spring H, Leier I, Keppler D. Mol Pharmacol. 1999;55:929–937. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/10220572/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Mol%20Pharmacol&author=Y%20Cui&author=J%20Konig&author=J%20K%20Buchholz&author=H%20Spring&author=I%20Leier&volume=55&publication_year=1999&pages=929-937&pmid=10220572&)]
  4. [16]Allen J D, Brinkhuis R F, van Deemter L, Wijnholds J, Schinkel A H. Cancer Res. 2000;60:5761–5766. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/11059771/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&author=J%20D%20Allen&author=R%20F%20Brinkhuis&author=L%20van%20Deemter&author=J%20Wijnholds&author=A%20H%20Schinkel&volume=60&publication_year=2000&pages=5761-5766&pmid=11059771&)]
  5. [17]McAllister R M, Corriell L L. Cancer Res. 1959;19:1040–1044. [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&author=R%20M%20McAllister&author=L%20L%20Corriell&volume=19&publication_year=1959&pages=1040-1044&)]
  6. [20]Lewin B. Genes V. Oxford, U.K.: Oxford Univ. Press; 1994. [[Google Scholar](https://scholar.google.com/scholar_lookup?title=Genes%20V&author=B%20Lewin&publication_year=1994&)]
  7. [24]Gartler S M, Pious D E. Humangenetik. 1966;2:83–114. [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Humangenetik&author=S%20M%20Gartler&author=D%20E%20Pious&volume=2&publication_year=1966&pages=83-114&)]
  8. [30]Bates S E. Clin Cancer Res. 1999;5:3346–3348. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/10589742/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&author=S%20E%20Bates&volume=5&publication_year=1999&pages=3346-3348&pmid=10589742&)]
  9. [31]Scheper R J, Broxterman H J, Scheffer G L, Kaaijk P, Dalton W S, van Heijningen T H, van Kalken C K, Slovak M L, de Vries E G, van der Valk P, et al. Cancer Res. 1993;53:1475–1479. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/7680954/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&author=R%20J%20Scheper&author=H%20J%20Broxterman&author=G%20L%20Scheffer&author=P%20Kaaijk&author=W%20S%20Dalton&volume=53&publication_year=1993&pages=1475-1479&pmid=7680954&)]
  10. [34]Young L C, Campling B G, Voskoglou-Nomikos T, Cole S P, Deeley R G, Gerlach J H. Clin Cancer Res. 1999;5:673–680. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/10100721/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&author=L%20C%20Young&author=B%20G%20Campling&author=T%20Voskoglou-Nomikos&author=S%20P%20Cole&author=R%20G%20Deeley&volume=5&publication_year=1999&pages=673-680&pmid=10100721&)]
  11. [40]Hassold T J. Trends Genet. 1986;2:105–110. [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Trends%20Genet&author=T%20J%20Hassold&volume=2&publication_year=1986&pages=105-110&)]
  12. [41]Heim S, Mitelman F. Cancer Cytogenet. New York: Wiley–Liss; 1995. [[Google Scholar](https://scholar.google.com/scholar_lookup?title=Cancer%20Cytogenet.&author=S%20Heim&author=F%20Mitelman&publication_year=1995&)]
  13. [50]Bocking A, Chatelain R. Anal Quant Cytol Histol. 1989;11:177–186. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/2663008/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Anal%20Quant%20Cytol%20Histol&author=A%20Bocking&author=R%20Chatelain&volume=11&publication_year=1989&pages=177-186&pmid=2663008&)]
  14. [53]Rasnick D, Duesberg P. Biochem J. 1999;340:621–630. [[PMC free article](/articles/PMC1220292/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/10359645/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Biochem%20J&author=D%20Rasnick&author=P%20Duesberg&volume=340&publication_year=1999&pages=621-630&pmid=10359645&)]
  15. [54]Li R, Sonik A, Stindl R, Rasnick D, Duesberg P. Proc Natl Acad Sci USA. 2000;97:3236–3241. doi: 10.1073/pnas.040529797. . (First Published March 21, 2000; 10.1073/pnas.040529797) [[DOI](https://doi.org/10.1073/pnas.040529797)] [[PMC free article](/articles/PMC16222/)] [[PubMed](https://pubmed.ncbi.nlm.nih.gov/10725343/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Proc%20Natl%20Acad%20Sci%20USA&author=R%20Li&author=A%20Sonik&author=R%20Stindl&author=D%20Rasnick&author=P%20Duesberg&volume=97&publication_year=2000&pages=3236-3241&pmid=10725343&doi=10.1073/pnas.040529797&)] · DOI
  16. [56]Hauschka T S, Levan A. Exp Cell Res. 1953;4:457–467. [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Exp%20Cell%20Res&author=T%20S%20Hauschka&author=A%20Levan&volume=4&publication_year=1953&pages=457-467&)]
  17. [57]Hauschka T S. Cancer Res. 1961;21:957–981. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/13712320/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&author=T%20S%20Hauschka&volume=21&publication_year=1961&pages=957-981&pmid=13712320&)]
  18. [58]Vogt M. J Cell Comp Physiol. 1958;52(Suppl.):271–285. [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=J%20Cell%20Comp%20Physiol&author=M%20Vogt&volume=52(Suppl.)&publication_year=1958&pages=271-285&)]
  19. [69]Hakala M T, Ishihara T. Cancer Res. 1962;22:987–992. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/13952013/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&author=M%20T%20Hakala&author=T%20Ishihara&volume=22&publication_year=1962&pages=987-992&pmid=13952013&)]
  20. [70]Biedler J L, Albrecht A M, Hutchison D J. Cancer Res. 1965;25:246–257. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/14264058/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&author=J%20L%20Biedler&author=A%20M%20Albrecht&author=D%20J%20Hutchison&volume=25&publication_year=1965&pages=246-257&pmid=14264058&)]
  21. [79]Gibbs W W. Sci Am. 2001;285:30–32. [[PubMed](https://pubmed.ncbi.nlm.nih.gov/11589196/)] [[Google Scholar](https://scholar.google.com/scholar_lookup?journal=Sci%20Am&author=W%20W%20Gibbs&volume=285&publication_year=2001&pages=30-32&pmid=11589196&)]

Cited by

Sorted by citations

Authors
Duesberg, P., Stindl, R., & Hehlmann, R.
Affiliations
  • Heidelberg University (DE)
  • Department of Molecular and Cell Biology, Stanley Hall, University of California, Berkeley, CA 94720; and III Medizinische Klinik Mannheim of the University of Heidelberg, Wiesbadener Strasse7-11, 68305 Mannheim, Germany
Venue
Proceedings of the National Academy of Sciences
Published
2001-09-11
Volume
98
Issue
20
Pages
11283-11288
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1979499502
Cited by
106
References
90
Citations by year
2026: 1 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 3 · 2021: 6 · 2020: 4 · 2019: 4 · 2018: 3 · 2017: 5 · 2016: 1 · 2015: 6 · 2014: 5 · 2013: 8 · 2012: 4
FWCI
2.81
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
Keywords
multidrug resistance, aneuploidy, karyotypic instability, mdr1a, mdr1b, MRP1, drug resistance genes, gene dosage, mouse cell lines, Chinese hamster cells, cancer chemotherapy resistance
MeSH terms
ATP-Binding Cassette Sub-Family B Member 4, Aneuploidy, Animals, Cell Line, Cell Survival, Chromosomes, Cytarabine, Cytotoxins, Dactinomycin, Demecolcine, Embryo, Mammalian, Cricetinae, Methotrexate, Puromycin, Transfection, CHO Cells, Drug Resistance, Multiple, ATP Binding Cassette Transporter, Subfamily B, ATP-Binding Cassette Transporters, Multidrug Resistance-Associated Proteins, ATP-Binding Cassette, Sub-Family C Proteins, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review